Viewing Study NCT00738257

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 7:07 PM
Ignite Modification Date: 2026-04-16 @ 6:47 PM
Study NCT ID: NCT00738257
Status: COMPLETED
Last Update Posted: 2010-05-17
First Post: 2008-08-18
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: A Prospective, Multicentre, Open-label Randomised Controlled Study to Investigate the Effectiveness of Pamidronate in the Prevention of Bone Loss in de Novo Renal Transplant Patients.
Sponsor: Novartis Pharmaceuticals
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Bone Loss View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Renal View
None transplant, View
None pamidronate, View
None ciclosporin, View
None Ciclosporin A, View
None steroids, View
None bone mineral density, View
None fracture rates View
None immunosuppressive View
None regimen View